Hu, C.; Zhou, Y.; Meng, X.; Li, J.; Chen, J.; Ying, Z.; Xie, X.S.; Hu, Y.; Cao, Y.; Jin, R.
Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial. Pharmaceutics 2025, 17, 43.
https://doi.org/10.3390/pharmaceutics17010043
AMA Style
Hu C, Zhou Y, Meng X, Li J, Chen J, Ying Z, Xie XS, Hu Y, Cao Y, Jin R.
Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial. Pharmaceutics. 2025; 17(1):43.
https://doi.org/10.3390/pharmaceutics17010043
Chicago/Turabian Style
Hu, Chaoying, Yibo Zhou, Xing Meng, Jianhua Li, Jinxia Chen, Zhifang Ying, Xiaoliang Sunney Xie, Yaling Hu, Yunlong Cao, and Ronghua Jin.
2025. "Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial" Pharmaceutics 17, no. 1: 43.
https://doi.org/10.3390/pharmaceutics17010043
APA Style
Hu, C., Zhou, Y., Meng, X., Li, J., Chen, J., Ying, Z., Xie, X. S., Hu, Y., Cao, Y., & Jin, R.
(2025). Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial. Pharmaceutics, 17(1), 43.
https://doi.org/10.3390/pharmaceutics17010043
